Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
The use of race in medical research.

JAMA

Phillips M.
PMID: 1593730
JAMA. 1992 Jun 17;267(23):3150-1. doi: 10.1001/jama.1992.03480230042013.

No abstract available.

Cite
Phillips M. The use of race in medical research. JAMA. 1992;267(23):3150-1doi: 10.1001/jama.1992.03480230042013.
Phillips, M. (1992). The use of race in medical research. JAMA, 267(23), 3150-1. https://doi.org/10.1001/jama.1992.03480230042013
Phillips, M. "The use of race in medical research." JAMA vol. 267,23 (1992): 3150-1. doi: https://doi.org/10.1001/jama.1992.03480230042013
Phillips M. The use of race in medical research. JAMA. 1992 Jun 17;267(23):3150-1. doi: 10.1001/jama.1992.03480230042013. PMID: 1593730.
Copy Download .nbib Format: NLM
Management of coexisting risk factors in hypertension--safe and sound?.

Blood pressure

Hedner T, Jern S, Hansson L.
PMID: 8746598
Blood Press. 1995 Nov;4(6):328. doi: 10.3109/08037059509077616.

No abstract available.

Cite
Hedner T, Jern S, Hansson L. Management of coexisting risk factors in hypertension--safe and sound?. Blood Press. 1995;4(6):328doi: 10.3109/08037059509077616.
Hedner, T., Jern, S., & Hansson, L. (1995). Management of coexisting risk factors in hypertension--safe and sound?. Blood pressure, 4(6), 328. https://doi.org/10.3109/08037059509077616
Hedner, T, et al. "Management of coexisting risk factors in hypertension--safe and sound?." Blood pressure vol. 4,6 (1995): 328. doi: https://doi.org/10.3109/08037059509077616
Hedner T, Jern S, Hansson L. Management of coexisting risk factors in hypertension--safe and sound?. Blood Press. 1995 Nov;4(6):328. doi: 10.3109/08037059509077616. PMID: 8746598.
Copy Download .nbib Format: NLM
John Laragh: scientific pioneer.

American journal of hypertension

Kurtz TW.
PMID: 25103932
Am J Hypertens. 2014 Aug;27(8):1010. doi: 10.1093/ajh/hpu107.

No abstract available.

Cite
Kurtz TW. John Laragh: scientific pioneer. Am J Hypertens. 2014;27(8):1010doi: 10.1093/ajh/hpu107.
Kurtz, T. W. (2014). John Laragh: scientific pioneer. American journal of hypertension, 27(8), 1010. https://doi.org/10.1093/ajh/hpu107
Kurtz, Theodore W. "John Laragh: scientific pioneer." American journal of hypertension vol. 27,8 (2014): 1010. doi: https://doi.org/10.1093/ajh/hpu107
Kurtz TW. John Laragh: scientific pioneer. Am J Hypertens. 2014 Aug;27(8):1010. doi: 10.1093/ajh/hpu107. PMID: 25103932.
Copy Download .nbib Format: NLM
MicroRNAs in arterial hypertension.

Current topics in medicinal chemistry

Synetos A, Toutouzas K, Stathogiannis K, Latsios G, Tsiamis E, Tousoulis D, Stefanadis C.
PMID: 23745804
Curr Top Med Chem. 2013;13(13):1527-32. doi: 10.2174/15680266113139990101.

Arterial hypertension is an epidemic currently affecting almost a billion people worldwide. The consequences from high blood pressure vary, from peripheral arterial disease and chronic kidney failure to acute myocardial infarction and stroke. MicroRNAs (miRNAs) are small non-coding RNA...

Cite
Synetos A, Toutouzas K, Stathogiannis K, et al. MicroRNAs in arterial hypertension. Curr Top Med Chem. 2013;13(13):1527-32doi: 10.2174/15680266113139990101.
Synetos, A., Toutouzas, K., Stathogiannis, K., Latsios, G., Tsiamis, E., Tousoulis, D., & Stefanadis, C. (2013). MicroRNAs in arterial hypertension. Current topics in medicinal chemistry, 13(13), 1527-32. https://doi.org/10.2174/15680266113139990101
Synetos, Andreas, et al. "MicroRNAs in arterial hypertension." Current topics in medicinal chemistry vol. 13,13 (2013): 1527-32. doi: https://doi.org/10.2174/15680266113139990101
Synetos A, Toutouzas K, Stathogiannis K, Latsios G, Tsiamis E, Tousoulis D, Stefanadis C. MicroRNAs in arterial hypertension. Curr Top Med Chem. 2013;13(13):1527-32. doi: 10.2174/15680266113139990101. PMID: 23745804.
Copy Download .nbib Format: NLM
From the editor.

Journal of the American Society of Hypertension : JASH

Weinberger MH.
PMID: 21531343
J Am Soc Hypertens. 2011 May-Jun;5(3):123-4. doi: 10.1016/j.jash.2011.03.009.

No abstract available.

Cite
Weinberger MH. From the editor. J Am Soc Hypertens. 2011;5(3):123-4doi: 10.1016/j.jash.2011.03.009.
Weinberger, M. H. (2011). From the editor. Journal of the American Society of Hypertension : JASH, 5(3), 123-4. https://doi.org/10.1016/j.jash.2011.03.009
Weinberger, Myron H. "From the editor." Journal of the American Society of Hypertension : JASH vol. 5,3 (2011): 123-4. doi: https://doi.org/10.1016/j.jash.2011.03.009
Weinberger MH. From the editor. J Am Soc Hypertens. 2011 May-Jun;5(3):123-4. doi: 10.1016/j.jash.2011.03.009. PMID: 21531343.
Copy Download .nbib Format: NLM
Essential hypertension in blacks: is it a metabolic disorder?.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Weir MR, Tuck ML.
PMID: 8465837
Am J Kidney Dis. 1993 Apr;21(4):58-67. doi: 10.1016/s0272-6386(12)80863-8.

No abstract available.

Cite
Weir MR, Tuck ML. Essential hypertension in blacks: is it a metabolic disorder?. Am J Kidney Dis. 1993;21(4):58-67doi: 10.1016/s0272-6386(12)80863-8.
Weir, M. R., & Tuck, M. L. (1993). Essential hypertension in blacks: is it a metabolic disorder?. American journal of kidney diseases : the official journal of the National Kidney Foundation, 21(4), 58-67. https://doi.org/10.1016/s0272-6386(12)80863-8
Weir, M R, and Tuck, M L. "Essential hypertension in blacks: is it a metabolic disorder?." American journal of kidney diseases : the official journal of the National Kidney Foundation vol. 21,4 (1993): 58-67. doi: https://doi.org/10.1016/s0272-6386(12)80863-8
Weir MR, Tuck ML. Essential hypertension in blacks: is it a metabolic disorder?. Am J Kidney Dis. 1993 Apr;21(4):58-67. doi: 10.1016/s0272-6386(12)80863-8. PMID: 8465837.
Copy Download .nbib Format: NLM
An update on biomarkers of heart failure in hypertensive patients.

Journal of hypertension

Gluba A, Bielecka-Dabrowa A, Bielecka A, Mikhailidis DP, Wong ND, Franklin SS, Rysz J, Banach M.
PMID: 22828089
J Hypertens. 2012 Sep;30(9):1681-9. doi: 10.1097/HJH.0b013e3283569a9c.

Biomarkers should have high sensitivity, specificity, reproducibility, be cost-effective, and provide incremental predictive or diagnostic utility over standard risk factors or tests. Despite numerous studies investigating biomarkers in heart failure (HF), there are only a few that predict HF...

Cite
Gluba A, Bielecka-Dabrowa A, Bielecka A, et al. An update on biomarkers of heart failure in hypertensive patients. J Hypertens. 2012;30(9):1681-9doi: 10.1097/HJH.0b013e3283569a9c.
Gluba, A., Bielecka-Dabrowa, A., Bielecka, A., Mikhailidis, D. P., Wong, N. D., Franklin, S. S., Rysz, J., & Banach, M. (2012). An update on biomarkers of heart failure in hypertensive patients. Journal of hypertension, 30(9), 1681-9. https://doi.org/10.1097/HJH.0b013e3283569a9c
Gluba, Anna, et al. "An update on biomarkers of heart failure in hypertensive patients." Journal of hypertension vol. 30,9 (2012): 1681-9. doi: https://doi.org/10.1097/HJH.0b013e3283569a9c
Gluba A, Bielecka-Dabrowa A, Bielecka A, Mikhailidis DP, Wong ND, Franklin SS, Rysz J, Banach M. An update on biomarkers of heart failure in hypertensive patients. J Hypertens. 2012 Sep;30(9):1681-9. doi: 10.1097/HJH.0b013e3283569a9c. PMID: 22828089.
Copy Download .nbib Format: NLM
[Biochemical aspects of arterial hypertension].

Settimana medica

MALFANTI PL.
PMID: 13765766
Settim Med. 1960 Dec 31;48:854-64.

No abstract available.

Cite
MALFANTI PL. [Biochemical aspects of arterial hypertension]. Settim Med. 1960;48:854-64
MALFANTI, P. L. (1960). [Biochemical aspects of arterial hypertension]. Settimana medica, 48854-64.
MALFANTI, P L. "[Biochemical aspects of arterial hypertension]." Settimana medica vol. 48 (1960): 854-64.
MALFANTI PL. [Biochemical aspects of arterial hypertension]. Settim Med. 1960 Dec 31;48:854-64. Italian. PMID: 13765766.
Copy Download .nbib Format: NLM
[Resistant hypertension: beyond a bad control of blood pressure].

Medicina clinica

Camafort M, Coca A.
PMID: 21719044
Med Clin (Barc). 2011 Oct 15;137(10):444-5. doi: 10.1016/j.medcli.2011.04.023. Epub 2011 Jun 29.

No abstract available.

Cite
Camafort M, Coca A. Hipertensión arterial resistente, más allá de un mal control de la presión arterial. [Resistant hypertension: beyond a bad control of blood pressure]. Med Clin (Barc). 2011;137(10):444-5doi: 10.1016/j.medcli.2011.04.023.
Camafort, M., & Coca, A. (2011). Hipertensión arterial resistente, más allá de un mal control de la presión arterial. [Resistant hypertension: beyond a bad control of blood pressure]. Medicina clinica, 137(10), 444-5. https://doi.org/10.1016/j.medcli.2011.04.023
Camafort, Miguel, and Coca, Antonio. "Hipertensión arterial resistente, más allá de un mal control de la presión arterial." [Resistant hypertension: beyond a bad control of blood pressure]. Medicina clinica vol. 137,10 (2011): 444-5. doi: https://doi.org/10.1016/j.medcli.2011.04.023
Camafort M, Coca A. Hipertensión arterial resistente, más allá de un mal control de la presión arterial. [Resistant hypertension: beyond a bad control of blood pressure]. Med Clin (Barc). 2011 Oct 15;137(10):444-5. doi: 10.1016/j.medcli.2011.04.023. Epub 2011 Jun 29. Spanish. PMID: 21719044.
Copy Download .nbib Format: NLM
Cardiometabolic crosstalk in obesity-associated arterial hypertension.

Reviews in endocrine & metabolic disorders

Jordan J, Birkenfeld AL.
PMID: 26961160
Rev Endocr Metab Disord. 2016 Mar;17(1):19-28. doi: 10.1007/s11154-016-9348-1.

Abdominal obesity and elevated blood pressure commonly occur in the same patient and are key components of the metabolic syndrome. However, the association between obesity and increased blood pressure is variable. We review mechanisms linking cardiovascular and metabolic disease...

Cite
Jordan J, Birkenfeld AL. Cardiometabolic crosstalk in obesity-associated arterial hypertension. Rev Endocr Metab Disord. 2016;17(1):19-28doi: 10.1007/s11154-016-9348-1.
Jordan, J., & Birkenfeld, A. L. (2016). Cardiometabolic crosstalk in obesity-associated arterial hypertension. Reviews in endocrine & metabolic disorders, 17(1), 19-28. https://doi.org/10.1007/s11154-016-9348-1
Jordan, Jens, and Birkenfeld, Andreas L. "Cardiometabolic crosstalk in obesity-associated arterial hypertension." Reviews in endocrine & metabolic disorders vol. 17,1 (2016): 19-28. doi: https://doi.org/10.1007/s11154-016-9348-1
Jordan J, Birkenfeld AL. Cardiometabolic crosstalk in obesity-associated arterial hypertension. Rev Endocr Metab Disord. 2016 Mar;17(1):19-28. doi: 10.1007/s11154-016-9348-1. PMID: 26961160.
Copy Download .nbib Format: NLM
The evaluation of metabolic factors in hypertension.

New York state journal of medicine

WEINSTEIN J, STEIN I.
PMID: 13552982
N Y State J Med. 1958 Jun 01;58(11):1857-62.

No abstract available.

Cite
WEINSTEIN J, STEIN I. The evaluation of metabolic factors in hypertension. N Y State J Med. 1958;58(11):1857-62
WEINSTEIN, J., & STEIN, I. (1958). The evaluation of metabolic factors in hypertension. New York state journal of medicine, 58(11), 1857-62.
WEINSTEIN, J, and STEIN, I. "The evaluation of metabolic factors in hypertension." New York state journal of medicine vol. 58,11 (1958): 1857-62.
WEINSTEIN J, STEIN I. The evaluation of metabolic factors in hypertension. N Y State J Med. 1958 Jun 01;58(11):1857-62. PMID: 13552982.
Copy Download .nbib Format: NLM
Type 2 diabetes mellitus and hypertension: an update.

Endocrinology and metabolism clinics of North America

Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR.
PMID: 24582094
Endocrinol Metab Clin North Am. 2014 Mar;43(1):103-22. doi: 10.1016/j.ecl.2013.09.005. Epub 2013 Dec 12.

Patients with hypertension and type 2 diabetes are at increased risk of cardiovascular and chronic renal disease. Factors involved in the pathogenesis of both hypertension and type 2 diabetes include inappropriate activation of the renin-angiotensin-aldosterone system, oxidative stress, inflammation,...

Cite
Lastra G, Syed S, Kurukulasuriya LR, et al. Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am. 2013;43(1):103-22doi: 10.1016/j.ecl.2013.09.005.
Lastra, G., Syed, S., Kurukulasuriya, L. R., Manrique, C., & Sowers, J. R. (2014). Type 2 diabetes mellitus and hypertension: an update. Endocrinology and metabolism clinics of North America, 43(1), 103-22. https://doi.org/10.1016/j.ecl.2013.09.005
Lastra, Guido, et al. "Type 2 diabetes mellitus and hypertension: an update." Endocrinology and metabolism clinics of North America vol. 43,1 (2014): 103-22. doi: https://doi.org/10.1016/j.ecl.2013.09.005
Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am. 2014 Mar;43(1):103-22. doi: 10.1016/j.ecl.2013.09.005. Epub 2013 Dec 12. PMID: 24582094; PMCID: PMC3942662.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries